German Association of Gynecology and Obstetrics Recommends HPV Testing for Cervical Cancer Screening
New cervical cancer prevention guidelines issued by the German Association for Gynecology and Obstetrics (DGGG) recommen…
New cervical cancer prevention guidelines issued by the German Association for Gynecology and Obstetrics (DGGG) recommen…
QIAGEN Gaithersburg, Inc. (formerly Digene Corporation), a wholly-owned subsidiary of QIAGEN N.V. (NASDAQ: QGEN; Frankfu…
QIAGEN (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) and privately held BioHelix have announced today that they have en…
. - 34% Constant Currency and 12% Organic Revenue Growth in 2007 - 31% Growth in Adjusted Net Income in 2007 - Fourth…
QIAGEN (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA), a leading provider of sample and assay technologies, and Bio*One…
Research demonstrating the potential of a special type of HPV test developed by QIAGEN with support from PATH – a non-pr…
. - 50% Revenue Growth - $0.17 Adjusted Diluted EPS - 43% Adjusted Operating Income Growth - Increasing Full Year 20…
QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) and Digene Corp. (Nasdaq: DIGE) announced that the antitrust…
Helix BioPharma Corp. (TSX, FSE: "HBP") announced today that it has initiated patient enrollment in a Phase II clinical…